| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 11/18/2010 | US20100291089 Ligand of regulating immune response, and use thereof in treating an immune response-related disease |
| 11/18/2010 | US20100291075 Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Neutralizing Antibodies |
| 11/18/2010 | US20100291074 Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease |
| 11/18/2010 | US20100291071 Antibody Specific Binding to A-Beta Oligomer and the Use |
| 11/18/2010 | US20100291065 Compositions for Protein Delivery and Methods of Use Thereof |
| 11/18/2010 | US20100291064 Compounds and Methods for the Treatment of Vascular Disease |
| 11/18/2010 | US20100291027 Hyaluronic acid (ha) injection vehicle |
| 11/18/2010 | US20100291021 Aliphatic prodrug linker |
| 11/18/2010 | US20100291004 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 11/18/2010 | US20100290995 Radio-opaque compounds, compositions containing same and methods of their synthesis and use |
| 11/18/2010 | US20100290993 Antibodies to IL-6 and use thereof |
| 11/18/2010 | US20100290987 Methods and compositions for detecting and modulating o-glycosylation |
| 11/18/2010 | US20100290986 Therapeutic use of diaminophenothiazines |
| 11/18/2010 | US20100290983 Compositions and Methods for Drug Delivery |
| 11/18/2010 | US20100288276 Compositions for treating parkinson's disease |
| 11/18/2010 | DE102009022046A1 Entfärbte Extrakte der Pflanze Pandanus conoideus Discolored extracts of the plant Pandanus conoideus |
| 11/18/2010 | CA2762107A1 Sublingual dexmedetomidine compositions and methods of use thereof |
| 11/18/2010 | CA2761853A1 Benzoxazolone derivatives as aldosterone synthase inhibitors |
| 11/18/2010 | CA2761771A1 Ranolazine for the treatment of cns disorders |
| 11/18/2010 | CA2761716A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors |
| 11/18/2010 | CA2761665A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide |
| 11/18/2010 | CA2761663A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof |
| 11/18/2010 | CA2761658A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof |
| 11/18/2010 | CA2761480A1 Lactoferrin and brain health and development in infants |
| 11/18/2010 | CA2761384A1 Treatment of stress |
| 11/18/2010 | CA2760837A1 7-([1,2,4]triazolo[1,5,-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| 11/18/2010 | CA2760741A1 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| 11/18/2010 | CA2760519A1 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 11/18/2010 | CA2760259A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 11/18/2010 | CA2760219A1 Oligomer-containing substituted aromatic triazine compounds |
| 11/18/2010 | CA2760084A1 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 11/18/2010 | CA2759180A1 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof |
| 11/18/2010 | CA2758202A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists |
| 11/17/2010 | EP2251424A1 Antigenic neisserial peptides |
| 11/17/2010 | EP2251350A2 RORalpha promoting the induction of Bmal1 |
| 11/17/2010 | EP2251341A1 Heterocyclic Janus kinase 3 inhibitors |
| 11/17/2010 | EP2251339A2 Compounds |
| 11/17/2010 | EP2251338A2 Organic compounds |
| 11/17/2010 | EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme |
| 11/17/2010 | EP2251032A1 Lactoferrin and brain health and protection in adults |
| 11/17/2010 | EP2251030A1 Lactoferrin and brain health and development in infants |
| 11/17/2010 | EP2251011A1 Solid preparation for oral administration |
| 11/17/2010 | EP2251010A1 Use of thiabendazole and derivatives thereof for the therapy of neurological conditions |
| 11/17/2010 | EP2251007A2 Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases |
| 11/17/2010 | EP2250176A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 11/17/2010 | EP2250170A1 Azaindole compounds for treatment of central nervous system disorders |
| 11/17/2010 | EP2250167A1 Arylmethylidene heterocycles as novel analgesics |
| 11/17/2010 | EP2250153A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 11/17/2010 | EP2250148A2 Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use |
| 11/17/2010 | EP2249874A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 11/17/2010 | EP2249872A1 Oligomer-diarylpiperazine conjugates |
| 11/17/2010 | EP2249868A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 11/17/2010 | EP2249865A2 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 11/17/2010 | EP2249861A1 Treating neurodegenerative diseases with progranulin (pgrn) |
| 11/17/2010 | EP2249856A2 Peptides that target dorsal root ganglion neurons |
| 11/17/2010 | EP2249848A1 Use of cannabinoids in combination with an anti-psychotic medicament |
| 11/17/2010 | EP2249847A2 Novel method for preparing extracts of ginkgo biloba |
| 11/17/2010 | EP2249840A1 Neuroactive steroid compositions and methods of use therefor |
| 11/17/2010 | EP2249833A1 Prodrugs of cgrp receptor antagonist |
| 11/17/2010 | EP2249828A1 Preparation of sulfamide derivatives |
| 11/17/2010 | EP2249822A1 Pharmaceutical compositions and methods utilizing a d-amino acid and an antioxidant for treating neuropsychiatric disorders |
| 11/17/2010 | EP2249821A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 11/17/2010 | EP1996291B1 Use of digitalis-like compounds in the treatment of affective disorders |
| 11/17/2010 | EP1931680B1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 11/17/2010 | EP1917264B1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/17/2010 | EP1838306B1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 11/17/2010 | EP1737856B1 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 11/17/2010 | EP1585525B1 Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| 11/17/2010 | EP1585522B1 Quinazolinones as potassium channel modulators |
| 11/17/2010 | EP1480616B1 Aerosol formulations of diisobutyryl apomorphine |
| 11/17/2010 | EP1476428B1 Pyridyl sulfone derivatives as 5-ht6 receptor ligands |
| 11/17/2010 | EP1280486B1 Minimizing adverse experience associated with oxybutynin therapy |
| 11/17/2010 | EP1032377B1 Substituted 2-aminoacetamides and the use thereof |
| 11/17/2010 | CN201630819U Brain-invigorating pillow |
| 11/17/2010 | CN201630814U Traditional Chinese medicine health-care pillow core and pillow |
| 11/17/2010 | CN201630813U Traditional Chinese medicine health-care pillow interior and pillow |
| 11/17/2010 | CN1907974B Huperzine with analgesic function and derivative thereof |
| 11/17/2010 | CN1863784B 2-naphthylimino-1,3-thiazine derivative |
| 11/17/2010 | CN101889010A Isoxazolo-pyridine derivatives |
| 11/17/2010 | CN101889004A Inhibitors of protein kinases |
| 11/17/2010 | CN101888990A Amide linked modulators of gamma-secretase |
| 11/17/2010 | CN101888877A Pyridine derivatives for the treatment of amyloid-related diseases |
| 11/17/2010 | CN101888842A Pharmaceutical preparation comprising stephaglabrin sulfate for treating demyelinating diseases of the nervous system and for promoting restoration of the myelin sheath of nerve fibers |
| 11/17/2010 | CN101888830A 透皮递送系统 Transdermal delivery systems |
| 11/17/2010 | CN101886066A Treatment effect of tissue plasminogen activator kringle-2 on stroke and preparation method for tissue plasminogen activator kringle-2 |
| 11/17/2010 | CN101885766A Novel neurotrophic factor, preparation thereof and application thereof |
| 11/17/2010 | CN101885735A Phenol hydroxy acid ester substituted phosphate compound, preparation method and application in medicines |
| 11/17/2010 | CN101885725A Pyrro-quinoline quinine sodium salt derivative and preparation method thereof |
| 11/17/2010 | CN101885697A Preparation method of Oxiracetam, product of Oxiracetam and use of product |
| 11/17/2010 | CN101884767A Plant extract composite for preventing diabetes complication and senium and preparation method thereof |
| 11/17/2010 | CN101884766A Healthcare product or medicine for preventing diabetes complication and senium and preparation method thereof |
| 11/17/2010 | CN101884765A Medicament for treating big belly known as beer belly |
| 11/17/2010 | CN101884744A Chinese medicinal preparation for treating cerebral neuradynamia |
| 11/17/2010 | CN101884743A Traditional Chinese medicine for treating insomnia and panasthenia |
| 11/17/2010 | CN101884741A Health preserving medicinal wine for nourishing yin and strengthening bones and preparation method thereof |
| 11/17/2010 | CN101884740A Chinese herb preparation for drug rehabilitation |
| 11/17/2010 | CN101884738A Chinese medicinal composition for treating panasthenia |
| 11/17/2010 | CN101884737A Chinese medicinal composition for treating hemiparalysis |
| 11/17/2010 | CN101884715A Medicament for treating optic neuritis and preparation method thereof |
| 11/17/2010 | CN101884646A Medicinal composition for preventing and treating Alzheimer's disease and senility and preparation method thereof |